A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection

Summary

The purpose of this study is to evaluate the effectiveness of guselkumab treatment compared with placebo (an inactive substance with no medicine) in preventing recurrence of Crohn's disease in participants after surgery.

Timeline

Start

2023-02-21

Primary completion

2023-09-29

Completion

2023-10-10

Outcome

Outcome not reported

Stopped (Business): “Janssen made an internal business decision to discontinue the PROGRESS study. This decision is not related to any efficacy or safety concerns.”

Drugs

Indications